HYDROXYPROGESTERONE CAPROATE Drug Patent Profile
✉ Email this page to a colleague
When do Hydroxyprogesterone Caproate patents expire, and when can generic versions of Hydroxyprogesterone Caproate launch?
Hydroxyprogesterone Caproate is a drug marketed by Allergan, Epic Pharma Llc, Aspen Global Inc, and Eugia Pharma. and is included in four NDAs.
The generic ingredient in HYDROXYPROGESTERONE CAPROATE is hydroxyprogesterone caproate. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydroxyprogesterone caproate profile page.
Summary for HYDROXYPROGESTERONE CAPROATE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 30 |
Patent Applications: | 5,401 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for HYDROXYPROGESTERONE CAPROATE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for HYDROXYPROGESTERONE CAPROATE |
What excipients (inactive ingredients) are in HYDROXYPROGESTERONE CAPROATE? | HYDROXYPROGESTERONE CAPROATE excipients list |
DailyMed Link: | HYDROXYPROGESTERONE CAPROATE at DailyMed |
Recent Clinical Trials for HYDROXYPROGESTERONE CAPROATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bezmialem Vakif University | N/A |
Assiut University | Phase 4 |
Aswan University Hospital | N/A |
Pharmacology for HYDROXYPROGESTERONE CAPROATE
Drug Class | Progestin |
Anatomical Therapeutic Chemical (ATC) Classes for HYDROXYPROGESTERONE CAPROATE
Paragraph IV (Patent) Challenges for HYDROXYPROGESTERONE CAPROATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
MAKENA (AUTOINJECTOR) | Injection (Auto- injector) | hydroxyprogesterone caproate | 275 mg/1.1 mL | 021945 | 1 | 2020-09-28 |